You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

2'-deoxyadenosine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Saint Louis (Selinexor, Cladribine, G-CSF)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 6, 2020

Investigation of ADA Enzyme Deficiency

Enrolling by invitation
  • Adenosine Deaminase Deficiency
  • adenosine deaminase test
  • Ankara, Mamak, Turkey
    Ankara Üniversitesi Tıp Fakültesi
Mar 18, 2022

Adenosine Deaminase Enzyme Deficiency in Lymphopenia and/or

Enrolling by invitation
  • Adenosine Deaminase Deficiency
  • ADENOSINE DEAMINASE TEST
  • Konya, Meram, Turkey
    Konya Necmettin Erbakan University
Mar 18, 2022

Enzyme Deficiency in Pulmonology Clinics (ADA)

Active, not recruiting
  • Bronchiectasis
  • +2 more
  • adenosine deaminase enzyme deficiency test
  • Ankara, Mamak, Turkey
    Ankara University Medical Faculty
Mar 18, 2022

Adenosine Deaminase Enzyme Deficiency Disease in Adult Pulmonary

Enrolling by invitation
  • Pulmonary Alveolar Proteinosis
  • adenosine deaminase test
  • Istanbul, Maltepe, Turkey
    Istanbul Yedikule Chest Diseases and Thoracic Surgery Training a
Mar 18, 2022

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia Trial in Seattle (Cladribine, Cytarabine,

Recruiting
  • Acute Biphenotypic Leukemia
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 18, 2022

Immune-mediated Diseases

Recruiting
  • Primary Immunodeficiency
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 10, 2023

    Adenosine Deaminase Severe Combined Immune Deficiency Trial (A cryopreserved formulation of autologous mPB CD34+ hematopoietic

    Not yet recruiting
    • Adenosine Deaminase Severe Combined Immune Deficiency
    • A cryopreserved formulation of autologous mPB CD34+ hematopoietic stem and progenitor cells transduced ex vivo with the EFS-ADA lentiviral vector encoding the human ADA enzyme
    • (no location specified)
    Jun 20, 2022

    Hairy Cell Leukemia Trial run by the NCI (Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin)

    Active, not recruiting
    Has Results
    • Hairy Cell Leukemia
    • Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 13, 2022

    Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

    Recruiting
    • Acute Biphenotypic Leukemia
    • +13 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 19, 2023

    Acute Myeloid Leukemia Trial in Houston (Azacitidine, Cladribine, Cytarabine)

    Recruiting
    • Acute Myeloid Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 17, 2022

    Acute Myeloid Leukemia, Blasts 20 Percent or More of Bone Marrow Nucleated Cells, High Risk Myelodysplastic Syndrome Trial in

    Recruiting
    • Acute Myeloid Leukemia
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 7, 2022

    AML, B-ALL, T-ALL Trial in Memphis (CD123-CAR T, Cyclophosphamide, Fludarabine)

    Recruiting
    • AML
    • +4 more
    • CD123-CAR T
    • +4 more
    • Memphis, Tennessee
    • +1 more
    May 10, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (procedure, drug, other)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 6, 2022

    Acute Myeloid Leukemia, Myeloproliferative Tumor, Myelodysplastic/Myeloproliferative Tumor Trial in Canada, United States

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Birmingham, Alabama
    • +9 more
    Aug 30, 2021

    Immunologic Deficiency Syndromes Trial in Milano (Strimvelis)

    Enrolling by invitation
    • Immunologic Deficiency Syndromes
    • Strimvelis
    • Milano, Lombardia, Italy
      Orchard Investigational Site
    Jun 23, 2021

    Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blasts 10 Percent or More of Bone Marrow

    Recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 31, 2022

    d in the Treatment of Multiple Sclerosis

    Not yet recruiting
    • Multiple Sclerosis
    • Measurement of concentrations of orally-used DMDs
    • +3 more
    • Ostrava, Moravian-Silesian Region, Czechia
    • +1 more
    Dec 5, 2022

    Adenosine Deaminase Deficiency, Severe Combined Immunodeficiencies (SCID) Trial in London (genetic, other, drug)

    Completed
    Has Results
    • Adenosine Deaminase Deficiency
    • Severe Combined Immunodeficiencies (SCID)
    • Infusion of autologous EFS-ADA LV CD34+ cells
    • +3 more
    • London, United Kingdom
      Great Ormond Street Hospital for Children NHS Foundation Trust
    Aug 20, 2021

    Secondary Acute Myeloid Leukemia Trial in Houston (Cladribine, Cytarabine, Uproleselan)

    Recruiting
    • Secondary Acute Myeloid Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 25, 2021

    Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)

    Recruiting
    • Acute Lymphoblastic Leukemia (ALL)
    • +7 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Oct 8, 2021

    Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (drug, biological, other)

    Completed
    Has Results
    • Acute Leukemia of Ambiguous Lineage
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Feb 23, 2022

    Acute Myeloid Leukemia Trial in Seattle (drug, biological, other)

    Active, not recruiting
    Has Results
    • Acute Myeloid Leukemia
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 10, 2022

    Duchenne Muscular Dystrophy Trial in Portland (NS-089/NCNP-02)

    Not yet recruiting
    • Duchenne Muscular Dystrophy
    • Portland, Oregon
      Shriners Hospital for Children
    Aug 16, 2023

    Respiratory Viral Infection, SARS CoV 2 Infection Trial in Banjul

    Active, not recruiting
    • Respiratory Viral Infection
    • SARS CoV 2 Infection
      • Banjul, Western Region, Gambia
        Field study in the West Coast Region and Kanifing Municipality C
      Jul 11, 2023